Hypothyroidism induced by immune checkpoint inhibitors combined with antiangiogenic agents is associated with higher body mass index

BACKGROUND: Recent studies have reported that the combination of immune checkpoint inhibitors (ICIs) and antiangiogenic agents could be a promising therapeutic strategy for advanced non-small cell lung cancer (NSCLC). However, both ICIs and antiangiogenic agents are associated with endocrine dysfunc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinyue, Chen, Xiuqiong, Zhou, Jing, Jiang, Richeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183541/
https://www.ncbi.nlm.nih.gov/pubmed/37197523
http://dx.doi.org/10.21037/jtd-23-306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183541/
https://www.ncbi.nlm.nih.gov/pubmed/37197523
http://dx.doi.org/10.21037/jtd-23-306

Ejemplares similares